You are here

Article metrics

Article menu
Download PDFPDF
Neurological dilemmas
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy

 

Online download statistics by month:

Online download statistics by month: April 2016 to October 2024

AbstractFullPdf
Apr 20162403063
May 2016620109145
Jun 20162484987
Jul 20161892246
Aug 20161073136
Sep 201659455195
Oct 201667261192
Nov 20165065987
Dec 20161882041
Jan 20172172456
Feb 2017964644
Mar 2017993131
Apr 20171224334
May 20171737250
Jun 20172124629
Jul 20171563320
Aug 20171351613
Sep 20172064726
Oct 20171723523
Nov 20171611712
Dec 2017872213
Jan 20181562119
Feb 20181382315
Mar 20181792615
Apr 20181723319
May 20181993715
Jun 20181761517
Jul 20181501912
Aug 20181512420
Sep 20181441720
Oct 20181302121
Nov 20181351720
Dec 2018125106
Jan 20191841511
Feb 20191211519
Mar 20191101415
Apr 2019932315
May 20195375
Jun 20198398
Jul 20191142518
Aug 20191051411
Sep 20197144
Oct 201980197
Nov 2019102910
Dec 20196995
Jan 20208086
Feb 2020701111
Mar 20205186
Apr 20203545
May 20204889
Jun 20205276
Jul 20205273
Aug 20205196
Sep 20206484
Oct 20205185
Nov 20206582
Dec 20204555
Jan 202173128
Feb 2021162739
Mar 20218097
Apr 20217494
May 202134108
Jun 20211387
Jul 202113117
Aug 2021744
Sep 20211184
Oct 20216477
Nov 20211091812
Dec 20218237
Jan 202211840
Feb 202266167
Mar 20228343
Apr 202213744
May 20229465
Jun 20227641
Jul 20221031510
Aug 2022142108
Sep 202212465
Oct 20228874
Nov 2022272123
Dec 20227053
Jan 20239391
Feb 2023100108
Mar 20238486
Apr 202311444
May 2023114109
Jun 202310141
Jul 20233252
Aug 2023103143
Sep 20235894
Oct 20239623
Nov 202325341
Dec 202315876
Jan 20244951
Feb 20246452
Mar 20248982
Apr 202412722
May 202411033
Jun 20248233
Jul 20247131
Aug 20244021
Sep 20245844
Oct 20245276
Total1304717781848